<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ra Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas Treco, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    AVROBIO, Inc.

    AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...

    AVROBIO, Inc., a leader in lentiviral-based gen...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    Otonomy, Inc.

    Otonomy, Inc.

    Otonomy is a biopharmaceutical company dedicated to the development of innovative ...

    Otonomy is a biopharmaceutical company dedicate...

    Filing Type:    PU
    Sophiris Bio, Inc.

    Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin ...

    Sophiris Bio Inc. is a late-stage biopharmaceut...

    Filing Type:    PU
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.